Vital Signs: Digital Health Law Update | Winter 2022

With 2022 well underway, the rapid pace of statutory, regulatory, policy, and industry activities in digital health continues in force. We bring you Vital Signs, a curated, one-stop resource on the most notable digital health law updates from our U.S. and global contributors.

As telehealth services have become expected from consumers, U.S. federal coverage is extended and expanded, along with a recent legislative proposal of permanency for telehealth flexibility. Similarly, state jurisdictions are taking steps […]

By | March 11th, 2022 ||

DOJ False Claims Act Recoveries Exceed $5.6 Billion In 2021

The U.S. Department of Justice (“DOJ”) recently announced that over $5.6 billion in False Claims Act (“FCA”) settlements and judgments had been reached during the 2021 fiscal year, with over $5 billion of those settlements coming from the healthcare industry. This year’s amount is the second largest in history,1 much of which is attributable to Purdue Pharma’s $2.8 billion settlement of allegations of submitting false claims to federal healthcare programs.2

In addition to a record year for FCA […]

By | March 10th, 2022 ||

Health Law Diagnosed — Transactions Part 1: Regulatory Trends In Recent Health Care Transactions (Podcast)

Health Law Diagnosed · Transactions Part 1: Regulatory Trends in Recent Health Care Transactions

2021 was a busy year for Mintz’s Health Law team, as they helped clients navigate complex health care transactions. Listen to hear the macro trends our team is seeing in the market, as well as their takeaways from the deals they closed.

By | March 9th, 2022 ||